La Chandra Pharmalab Private Limited

La Chandra Pharmalab is a cGMP-compliant company established in 2015, focused on the manufacturing of niche Hormone Active Pharmaceutical Ingredients (APIs). Our work is driven by purpose Science for Health to develop niche & challenging APIs for the Pharmaceutical Industry. Commercial operations started in 2016 from cGMP manufacturing facility near Palanpur, Gujarat, India which has several tons capacity and spread over 10,186 sq. meters with optimal infrastructure and technological capabilities supported by a state-of-the-art R&D centre, well equipped Quality Control, Warehouse and Utilities. Our Hormone product portfolio includes Progesterone, Estradiol Hemihydrate, Norethisterone Acetate, Norethisterone, Mifepristone, Dydrogesterone, Dydrogesterone intermediates, Hydroxyprogesterone Caproate and Medroxyprogesterone Acetate. Our manufacturing site has been accredited with WHO-GMP and Written Confirmation (EU-GMP). CEP for Progesterone (R0-CEP 2017-207 - Rev 00) has been granted by EDQM and we have supported customers for their registrations in regulated and semi-regulated markets. Our clientele includes some of the top pharma companies in India and abroad and this growth is fueled by a continual focus on product development through R&D, cGMP compliant production, regulatory compliance and filings and a stringent quality control that ensures the highest standards of product quality. USFDA FEI No.: 3030266602 Corporate Office DUNS No: 876817676 Mfg. Site DUNS No: 643512763